Jeffrey Bluestone

CIK: 0001771814

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (40.9%)

Position reduction

Option Exercises (M)10 (45.5%)

Derivative conversions

Awards (A)3 (13.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GILD

GILEAD SCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (22 total)

GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Sale(S)
Direct
26 shares at avg. $146.36$4K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Sale(S)
Direct
335 shares at avg. $146.26$49K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Exercise(M)
Direct
335 shares at avg. $61.35$21K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Exercise(M)
Direct
1.2K shares at avg. $67.45$79K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Sale(S)
Direct
1.2K shares at avg. $143.75$167K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Exercise(M)
Direct
1.8K shares at avg. $67.45$122K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Sale(S)
Direct
1.8K shares at avg. $144.92$263K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Exercise(M)
Direct
1.7K shares at avg. $67.45$112K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Sale(S)
Direct
1.7K shares at avg. $145.73$242K
GILD
GILEAD SCIENCES, INC.
Aug 20, 2026
Exercise(M)
Direct
26 shares at avg. $67.45$2K
GILD
GILEAD SCIENCES, INC.
Apr 30, 2026
Award(A)
Direct
1.1K shares-
GILD
GILEAD SCIENCES, INC.
Jan 20, 2026
Sale(S)
Direct
5K shares at avg. $123.50$618K
GILD
GILEAD SCIENCES, INC.
Jan 20, 2026
Exercise(M)
Direct
5K shares at avg. $67.45$337K
GILD
GILEAD SCIENCES, INC.
Nov 28, 2025
Sale(S)
Direct
5K shares at avg. $125.08$625K
GILD
GILEAD SCIENCES, INC.
Nov 28, 2025
Exercise(M)
Direct
5K shares at avg. $64.92$325K
GILD
GILEAD SCIENCES, INC.
Jul 14, 2025
Exercise(M)
Direct
5K shares at avg. $67.45$337K
GILD
GILEAD SCIENCES, INC.
Jul 14, 2025
Sale(S)
Direct
5K shares at avg. $109.74$549K
GILD
GILEAD SCIENCES, INC.
May 7, 2025
Award(A)
Restricted Stock Unit
Direct
1.5K shares-
GILD
GILEAD SCIENCES, INC.
May 7, 2025
Award(A)
Non-qualified Stock Option (Right to Buy)
Direct
6.8K shares-
GILD
GILEAD SCIENCES, INC.
Nov 26, 2024
Sale(S)
Direct
6.8K shares at avg. $91.39$620K
GILD
GILEAD SCIENCES, INC.
Nov 26, 2024
Exercise(M)
Direct
4.1K shares at avg. $61.35$253K
GILD
GILEAD SCIENCES, INC.
Nov 26, 2024
Exercise(M)
Direct
5.9K shares at avg. $61.17$360K

		Type	Shares	Price		Ownership
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Sale(S)	26	$146.36	$3,805	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Sale(S)	335	$146.26	$48,997	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	335	$61.35	$20,552	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	1,165	$67.45	$78,579	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Sale(S)	1,165	$143.75	$167,474	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	1,816	$67.45	$122,489	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Sale(S)	1,816	$144.92	$263,183	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	1,658	$67.45	$111,832	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Sale(S)	1,658	$145.73	$241,618	Direct
Aug 20, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	26	$67.45	$1,754	Direct
Apr 30, 2026	GILD GILEAD SCIENCES, INC.	Award(A)	1,146	-	$0	Direct
Jan 20, 2026	GILD GILEAD SCIENCES, INC.	Sale(S)	5,000	$123.50	$617,500	Direct
Jan 20, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	5,000	$67.45	$337,250	Direct
Nov 28, 2025	GILD GILEAD SCIENCES, INC.	Sale(S)	5,000	$125.08	$625,400	Direct
Nov 28, 2025	GILD GILEAD SCIENCES, INC.	Exercise(M)	5,000	$64.92	$324,600	Direct
Jul 14, 2025	GILD GILEAD SCIENCES, INC.	Exercise(M)	5,000	$67.45	$337,250	Direct
Jul 14, 2025	GILD GILEAD SCIENCES, INC.	Sale(S)	5,000	$109.74	$548,700	Direct
May 7, 2025	GILD GILEAD SCIENCES, INC.	Award(A) Restricted Stock Unit	1,516	-	-	Direct
May 7, 2025	GILD GILEAD SCIENCES, INC.	Award(A) Non-qualified Stock Option (Right to Buy)	6,809	-	-	Direct
Nov 26, 2024	GILD GILEAD SCIENCES, INC.	Sale(S)	6,788	$91.39	$620,356	Direct
Nov 26, 2024	GILD GILEAD SCIENCES, INC.	Exercise(M)	4,121	$61.35	$252,823	Direct
Nov 26, 2024	GILD GILEAD SCIENCES, INC.	Exercise(M)	5,879	$61.17	$359,618	Direct

1-22 of 22 transactions

About Bluestone Jeffrey

Bluestone Jeffrey (SEC CIK 0001771814) files insider reports with the SEC as Director of GILEAD SCIENCES, INC. (GILD).

Signal8 holds 7 ownership filings by Bluestone Jeffrey, all Form 4s, filed between Nov 27, 2024 and Aug 21, 2026. Those filings report 22 transactions, from Nov 26, 2024 to Aug 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bluestone Jeffrey's filings is in FOSTER CITY, CA.

Recent filings by Bluestone Jeffrey

Aug 20, 2026: Open-market sales of GILD shares (2 lines, Form 4, code S).
Aug 20, 2026: Option exercises of GILD shares (2 lines, Form 4, code M).
Aug 20, 2026: Open-market sale of GILD shares (Form 4, code S).
Aug 20, 2026: Option exercise of GILD shares (Form 4, code M).
Aug 20, 2026: Open-market sale of GILD shares (Form 4, code S).

Other insiders filing for GILEAD SCIENCES, INC. (GILD)

O'Day Daniel Patrick, Chairman & CEO
Dickinson Andrew D, Chief Financial Officer
Mercier Johanna, Chief Comm & Corp Aff Officer
Burkhart Erin, SVP, Controllership
Berger Dietmar, Chief Medical Officer
Cain Wettan Keeley M, EVP Gen Counsel, Legal & Comp

How to read Form 4 transaction codes